This post is a nonsense - perhaps you could include some substance in your post to give your argument a little credibility?
The new shares are from what has been called the best capital raise of 2019 - directors buying lots of shares at a premium.
Their strategy is clear and if they are successful at simply the stuff that's on the table right now then it could be a $3+ stock ($100m for the PRV and $350m for Bisantrene)
DYOR
This post is a nonsense - perhaps you could include some...
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.64 |
Change
-0.050(2.96%) |
Mkt cap ! $269.2M | |||
| Open | High | Low | Value | Volume |
| $1.66 | $1.66 | $1.57 | $244.8K | 150.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1765 | $1.64 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.65 | 1400 | 1 |
View Market Depth
| Last trade - 12.38pm 04/10/2024 (20 minute delay) ? |
| RAC (ASX) Chart |